Reported Dec 24, 2014 · Terminated

BELVIQ¿ (Lorcaserin HCl) Tablets, 10 mg, 60-count bottle, Rx only, Manufactured by: Arena Pharmaceuticals, GmbH,…

Eisai Inc.

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Eisai Inc · 900 Davis Drive · Research Triangle Park, NC · 27709

Is this the product you have?

  • BELVIQ¿ (Lorcaserin HCl) Tablets, 10 mg, 60-count bottle, Rx only
  • Manufactured byArena Pharmaceuticals, GmbH, Zofingen, Switzerland
  • Distributed byElsai Inc., Woodcliff, NJ 07677 NDC 62856-52960
Lot codes and dates
    • Lot #13297008
    • Exp. 11/15
    • 13307008
    • Exp. 11/15
    • 13367008
    • Exp.12/15
Amount recalled
121,680 bottles

Where it was sold

  • Nationwide

Why it was recalled

Labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot number and/or expiry date.

This product is unlikely to cause harm, but it breaks a safety or labelling rule.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Eisai Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated May 21, 2015 · Data as of Sep 19, 7:16 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.